COMMUNIQUÉS West-GlobeNewswire

Trading in Coloplast shares by board members, executives or associated persons

29/08/2018 - 17:40

Nasdaq Copenhagen 29 August 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on [...]

RAMSAY GENERALE DE SANTE : annual Results at the end of June 2018

29/08/2018 - 17:36

PRESS RELEASE Paris, 29 August 2018 Annual results at the end of June 2018 Resilient operating results in an unfavourable context Annual published turnover rose 0.3% to EUR 2,241.5 million (a 0.7% increase on a like-for [...]

RAMSAY GENERALE DE SANTE : résultats annuels à fin juin 2018

29/08/2018 - 17:36

COMMUNIQUE DE PRESSE Paris, le 29 Août 2018 Résultats annuels à fin juin 2018 Des résultats opérationnels résilients dans un contexte défavorable Chiffre d'affaires annuel publié en hausse de 0,3% à 2241,5 millions d' [...]

The Alliance for Regenerative Medicine Releases Agenda for 2018 Cell & Gene Meeting on the Mesa

29/08/2018 - 16:44

WASHINGTON, DC, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative [...]

Departure of Managing Director & Chief Executive Officer

29/08/2018 - 16:23

SYDNEY, Australia and MINNEAPOLIS, Aug. 29, 2018 (GLOBE NEWSWIRE) -- The Board of Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF) , today announced that Mr. Jack Cosentino will cease as Managing Director [...]

Tempus Announces $110 Million in Series E Financing

29/08/2018 - 16:00

CHICAGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today it has secured an [...]

Easton Pharmaceuticals to Participate in a Casino and Hotel Resort Project in Europe with Projected Revenues in Excess of 77 Million Euro Per Annum

29/08/2018 - 15:41

TORONTO, ON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces that it has entered into a Letter of Intent to acquire an interest or participate in the development [...]

Addressing a Leading Cause of Pregnancy-Related Death Among U.S. Women

29/08/2018 - 15:35

Stop the Clot, Spread the Word™ Public Health Education Effort Emphasizes Preventing Blood Clots in Pregnant Women VIENNA, Va., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Blood clots are a leading cause of pregnancy-related [...]

Patent reinforces AroCell’s opportunities in the US market

29/08/2018 - 15:15

AroCell AB has received a Notice of Allowance stating that the U.S. Patent and Trademark Office intends to grant the company's patent application no. 15/105,999 titled ”Monoclonal Anti-TK1 Antibodies”. The patent [...]

Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018

29/08/2018 - 15:01

SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]

ProLynx and Daiichi Sankyo announce the development of technology for half-life extension of small molecules in the eye

29/08/2018 - 15:00

SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- ProLynx and Daiichi Sankyo Company, Limited, announced today the publication of a paper in the journal TVST entitled “A controlled release system for long-acting [...]

MannKind Corporation to Present at Upcoming Conferences

29/08/2018 - 15:00

WESTLAKE VILLAGE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such [...]

High Hampton Holdings Expands California Network with CaliGold Acquisition -- CFN Media

29/08/2018 - 15:00

SEATTLE, Aug. 29, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

New Data on NOCTIVA™ Presented at the 2018 International Continence Society Meeting

29/08/2018 - 14:35

Data demonstrate meaningful reduction in nocturic episodes, extended first uninterrupted sleep period, and improved quality of life for patients suffering from nocturia due to nocturnal polyuria DUBLIN, Ireland, Aug. 29 [...]

Globus Medical to Exhibit Latest Advancements in MIS Spine Surgery at SMISS Annual Forum

29/08/2018 - 14:30

AUDUBON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and navigation system along [...]

Albireo to Present at the H.C. Wainwright Global Investment Conference

29/08/2018 - 14:30

BOSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]

ChromaDex to Present at the 7th Annual Liolios Gateway Conference on September 6, 2018

29/08/2018 - 14:30

IRVINE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and [...]

Ultragenyx Announces FDA Accepts Proposal to Submit an NDA for UX007 for the Treatment of Long-Chain Fatty Acid Oxidation Disorders

29/08/2018 - 14:30

NOVATO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced [...]

Avinger Receives New Patent Covering Pantheris Image-Guided Atherectomy System

29/08/2018 - 14:30

Extensive Intellectual Property Portfolio Now Includes 131 Patents and Applications REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for [...]